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Identification of Three Hidradenitis Suppurativa
Phenotypes: Latent Class Analysis of a Cross-Sectional
Study
Florence Canoui-Poitrine1,2,6, Aure´lie Le Thuaut1,2,3,6, Jean E. Revuz4, Ce´dric Viallette1,3, Germaine Gabison5,
Florence Poli5, Florence Pouget5, Pierre Wolkenstein1,5 and Sylvie Bastuji-Garin1,2,3
To identify the underlying subtypes of hidradenitis suppurativa (HS), we performed latent class analysis on
prospective clinical data of 618 consecutive patients seen between 2002 and 2010. The median patient age was 31
years (Q1¼ 26; Q3¼ 38), median age at HS onset was 20 years (16–25), and median Sartorius score was 18
(11–19); 34.4% of patients were of Hurley stage II or III. A three-class model showed the best fit. Latent class 1
(LC1) patients (48%) had a high probability of breast and armpit lesions (0.74) and hypertrophic scars (0.41). LC2
patients (26%) had a high probability not only of breast and armpit lesions (0.96) but also of lesions in the ears,
chest, back, or legs (0.55); follicular lesions (pilonidal sinus: 0.48; comedones: 0.74); severe acne (0.47); and a family
history of HS (0.44). Compared with LC1 patients, LC2 patients were more often male (odds ratio, 4.6; 95%
confidence interval, 3–7; Po0.001) and current smokers (2.2; 1.3–3.9; P¼ 0.005), and had greater disease severity
(odds ratio, 1.6; 1.3–1.9; Po0.001). LC3 was characterized by gluteal involvement (0.54), papules, and folliculitis
(0.71). LC3 patients were less often obese (0.6; 0.3–0.95; P¼ 0.03) and had less severe disease (0.9; 0.7–1.1; Po0.001).
These three phenotypes (‘‘axillary–mammary’’, ‘‘follicular’’, and ‘‘gluteal’’) may help stratify patients for clinical
trials.
Journal of Investigative Dermatology (2013) 133, 1506–1511; doi:10.1038/jid.2012.472; published online 13 December 2012
INTRODUCTION
Hidradenitis suppurativa (HS) is a chronic inflammatory
disease of the apocrine gland–bearing skin. Recurrent, painful,
deep-seated lesions develop chiefly in the axillary, inguinal,
and anogenital regions. The onset of this debilitating disease
usually occurs after puberty. The pathogenesis remains
unclear, and the roles for inflammation and bacterial infection
are not well documented (Jemec et al., 1996; Kurzen et al.,
2008; Alikhan et al., 2009; Nazary et al., 2011). The
prevalence of HS has been estimated at 1% in the general
population, with higher values among women (Revuz et al.,
2008). The diagnosis is exclusively clinical and relies on the
presence of the following: typical lesions, i.e., deep-seated
painful nodules, abscesses, draining sinuses, and bridged
scars; typical topography, with predominant involvement of
the axillae and groin; and chronic course with multiple
recurrences (Revuz, 2009). Although the typical patient is a
young woman with axillary and groin involvement, the
spectrum of presentations is broad (Jemec, 2012).
Considerable variability also occurs in disease severity,
which is assessed using the Hurley stage (Hurley, 1989) or
Sartorius score (Sartorius et al., 2003). The lack of knowledge
about HS and extremely heterogenous clinical presentation in
terms of both lesion appearance and sites of involvement
frequently delay the diagnosis for several years (Sartorius et al.,
2010). An ability to classify HS patients would help in
conducting studies aimed at elucidating the etiology of HS
and at developing effective treatments (Everitt, 1995).
Given the heterogeneity of HS, we hypothesized that the
underlying subclasses could be individualized. The objectives
of this study were to build an empirical classification scheme
without any a priori hypotheses in order to identify the
underlying HS subtypes that best explained the observed
heterogeneity, and to validate this classification scheme on
the basis of demographics, medical history, and severity. To
achieve these goals, we used latent class analysis (LCA).
RESULTS
Between 2002 and 2010, 648 consecutive patients were
included. As the classification methods can be applied only
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to observations with complete data, we confined our analysis
to the 618 (95.4%) patients without missing data. The median
age was 31 years (26–38), median age at HS onset was 20
years (16–25), and median HS duration was 9 years (4–15). Of
the 618 patients, 72.8% were current smokers and 10.4%
were past smokers. The median Sartorius score was 18
(11–19); 27.4% patients were of Hurley stage II and 7% stage III.
Table 1 displays the goodness-of-fit statistics for one-class to
eight-class models. A three-class model showed the best fit,
with the lowest Bayesian information criterion. Table 2 reports
the conditional probabilities of the 10 previously selected
indicators among the three latent classes (LCs), interpreted as
the probability of each indicator being present in class
members. Of the 618 patients, 299 (48%) belonged to LC1,
161 (26%) to LC2, and 158 (26%) to LC3. LC1 patients had
high probabilities for breast and armpit involvement and for
hypertrophic scars. In LC2 patients, probabilities were high not
only for breast and armpit involvement but also for involve-
ment of the ears, chest, back, or legs; these patients had high
probabilities for all lesion types but had higher probabilities
than the patients in the other two classes for follicular lesions
(epidermal cysts, pilonidal sinus, and comedones) and for a
present or past history of severe acne. LC3 patients were
characterized by gluteal involvement, follicular papules, and
folliculitis. Consequently, we chose the following terms to
designate the three classes: LC1, ‘‘axillary–mammary’’; LC2,
‘‘follicular’’; and LC3, ‘‘gluteal’’.
Table 3 compares patient and disease characteristics across
the three LCs. Significant differences were found among the
three LCs for gender, body mass index (BMI), smoking status,
severity scores, age at disease onset, and HS duration.
Compared with the ‘‘axillary–mammary’’ class (LC1, the
reference category), the ‘‘follicular’’ class (LC2) was charac-
terized by higher proportions of men and current/former
smokers, greater disease severity (Sartorius and Hurley), earlier
disease onset, and longer disease duration. Patients in the
‘‘gluteal’’ class (LC3) were more often smokers, and had lower
BMI values and less severe disease despite a longer disease
duration than in the ‘‘axillary–mammary’’ class.
Compared with the ‘‘gluteal’’ class (LC3), the ‘‘follicular’’
class had a higher proportion of men, higher mean BMI and
severity score values, and a longer disease duration.
DISCUSSION
We report a previously unreported empirical classification of
HS based on LCA of clinical variables. Our results indicate the
existence of three classes. The first class comprised 48% of the
study population and was characterized by high prevalences
of breast and armpit involvement and of hypertrophic scars.
Our classification makes clinical sense, as it fitted with typical
and atypical clinical observations. The ‘‘axillary–mammary’’
class corresponds to the typical form described in dermatology
practice, whereas the other two classes (‘‘follicular’’ and
‘‘gluteal’’) correspond to atypical forms (Jemec, 2012). The
‘‘follicular’’ class (26% of patients) was characterized by
follicular lesions, most notably epidermal cysts, pilonidal
sinus, and comedones, and by severe acne. The ‘‘follicular’’
Table 1. Fit of the models with one to eight classes
N of classes N of estimated model parameters BIC
1 10  3049.919
2 21  3131.976
3 32  3148.100
4 43  3112.336
5 54  3065.521
6 65  3007.969
7 76  2958.721
8 87  2899.641
Abbreviation: BIC, Bayes information criterion.
Bold entry indicates the model with the best fit.
Table 2. Parameter estimates for the three LC solution
in 618 patients with hidradenitis suppurativa
Prevalence of
indicators
among the
618 patients,
N (%)
LC1
‘‘axillary–
mammary’’
(N¼299)
LC2
‘‘follicular’’
(N¼ 161)
LC3
‘‘gluteal’’
(N¼158)
Probability of
membership in
each class
0.48 0.26 0.26
Conditional probabilities1 of:
Locations
Armpit and/
or breast2
444 (71.8) 0.74 0.96 0.45
Gluteal area 187 (30.3) 0.12 0.37 0.54
Ears and/or
chest and/or
others2
138 (22.3) 0.06 0.55 0.18
Lesion types
Hypertophic
scars
206 (33.3) 0.41 0.54 0.01
Comedones 274 (44.3) 0.25 0.74 0.49
Epidermal
cysts and/or
macrocysts2
52 (8.4) 0.04 0.23 0.01
Papules and
folliculitis
280 (45.3) 0.23 0.71 0.71
Pilonidal
sinus
188 (30.4) 0.27 0.48 0.18
Family history
of HS
219 (35.4) 0.29 0.44 0.37
Acne and/or
history of
severe acne2
165 (26.7) 0.21 0.47 0.16
Abbreviations: HS, hidradenitis suppurativa; LC, latent class.
1Probability of each indicator among patients of this class.
2At least one present on the evaluation day.
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class had higher proportions of men and smokers (current
and former), greater disease severity, earlier disease onset,
and longer disease duration compared with the typical
‘‘axillary–mammary’’ class. The ‘‘gluteal’’ class was charac-
terized by gluteal involvement, follicular papules, and
folliculitis, with a higher proportion of smokers, lower BMI,
Table 3. Univariate comparisons of patients and disease characteristics among the three latent classes identified in
618 patients with hidradenitis suppurativa
Comparison of the three latent classes
Multinomial logistic
regression with class LC1 as
the reference category P-value1
Overall
population
(N¼ 618)
‘‘Axillary–
mammary’’
(LC1) (N¼299)
‘‘Follicular’’
(LC2)
(N¼ 161)
‘‘Gluteal’’
(LC3)
(N¼158)
P-
value2
‘‘Follicular’’
(LC2)
‘‘Gluteal’’
(LC3)
LC2
versus
LC1
LC3
versus
LC1
LC2
versus
LC3
N (%) N (%) N (%) N (%) OR (95% CI) OR (95% CI)
Male
gender
170 (27.5) 54 (18.1) 81 (50.3) 35 (22.1) o0.001 4.6 (3.0–7.0) 1.3 (0.8–2.1) o0.001 0.29 o0.001
BMI 3,
kg m 2
24.6 (21.6–29.4) 24.6 (21.8–29.7) 25.7 (22.8–30) 23.5 (20.7–27.1) o0.001
o25 325 (52.6) 155 (51.8) 73 (45.3) 97 (61.4) 1 1
(25–30) 156 (25.2) 73 (24.4) 47 (29.2) 36 (22.8) 0.05 1.4 (0.9–2.2) 0.8 (0.5–1.3) 0.18 0.32 0.04
X30 137 (22.2) 71 (23.8) 41 (25.5) 25 (15.8) 1.3 (0.8–2.0) 0.6 (0.3–0.95) 0.4 0.03 0.01
Smoking status
Never
smoker
104 (16.8) 70 (23.4) 19 (11.8) 15 (9.5) 1 1
Current
smoker
450 (72.8) 200 (66.9) 120 (74.5) 130 (82.3) o0.001 2.2 (1.3–3.9) 3.0 (1.7–5.5) 0.005 o0.001 0.39
Past
smoker
64 (10.4) 29 (9.7) 22 (13.7) 13 (8.2) 2.8 (1.4–6.0) 2.1 (0.9–4.9) 0.007 0.09 0.56
Hurley stage
I 367 (65.6) 165 (62.0) 78 (52.4) 124 (86.1) 1 1
II 153 (27.4) 77 (29.0) 58 (38.9) 18 (12.5) o0.001 1.6 (1.1–2.5) 0.3 (0.2–0.6) 0.04 o0.001 o0.001
III 39 (7.0) 24 (9.0) 13 (8.7) 2 (1.4) 1.2 (0.6–2.4) 0.1 (0.03–0.5) 0.71 0.003 0.003
Sartorius
score3
18 (11–19) 17 (10–26) 26 (15–36) 16 (11–23) o0.001
o13.5
(1st
tertile)
213 (34.5) 120 (40.1) 35 (21.7) 58 (36.7) 1 1
(13.5–24) 204 (33.0) 96 (32.1) 43 (26.8) 65 (41.1) o0.001 1.5 (0.9–2.6) 1.4 (0.9–2.2) 0.11 0.14 0.75
X25 201 (32.5) 83 (27.8) 83 (51.5) 35 (22.1) 3.4 (2.1–5.6) 0.87 (0.5–1.4) o0.001 0.6 o0.001
Age at
HS onset,
years3,4
20 (16–25) 21 (17–26) 18 (15–22) 20 (16–26) o0.001 0.96 (0.9–0.99) 0.99 (0.97–1) o0.01 0.5 0.03
HS
duration,
years3,4
9 (4–15) 7 (3–13) 13(7–20) 10 (6–15) o0.001 1.07 (1.04–1.1) 1.03 (1–1.02) o0.001 0.03 0.01
Abbreviations: BMI, body mass index; CI, confidence interval; HS, hidradenitis suppurativa; LC, latent class; OR, odds ratio.
1P-values from pairwise analyses; threshold¼0.016 according to Bonferroni’s correction.
2P-values from w2 or Kruskal–Wallis tests, as appropriate, for overall comparisons of the three latent classes.
3Expressed as median (interquartile range).
4Age and disease duration were simultaneously adjusted for each other.
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and decreased disease severity, despite a longer HS duration
compared with the ‘‘axillary–mammary’’ class.
No formal description of clinicopathological subsets of HS
has been published to date. However, differences in topo-
graphic lesion distribution have been described on the basis of
observations from everyday practice. Thus, women usually
have lesions in the anterior part of the body (breasts, axillae,
and genito–femoral area), often with hypertrophic scars
(Jemec, 1988; Jansen et al., 2001). Similarly, in a previous
study of 302 patients, also included in the present work, we
found that the front of the body was more often affected in
women and the back of the body in men (Canoui-Poitrine
et al., 2009); furthermore, lesions at atypical sites such as the
ears and chest and the presence of pilonidal cysts were more
common in men (Canoui-Poitrine et al., 2009). Another study
also found that men had higher prevalences of atypical
features, such as involvement of the gluteal area, face, and
back (Poli et al., 2010; Jemec, 2012). Thus, our findings based
on a statistical method with no predefined hypothesis are
consistent with the previously reported heterogeneity of HS
and with descriptions of a number of clinical features.
Moreover, we were able to separate two ‘‘atypical’’ forms,
one with gluteal involvement seen predominantly in men and
the other with a predominance of folliculitis lesions.
Our study has several strengths. It is a previously unreported
attempt at building a classification of HS patients. The strength
of classification methods is to identify phenotypes without a
priori hypothesis. These methods cannot establish the fact that
proposed clusters correspond to a clear etiological subtype.
They proved, however, to be effective tools for determining
heterogeneity in the data and suggesting new hypothesis. We
chose the LCA method, a well-established method for classify-
ing patients with similar patterns. Many methods have been
suggested for constructing a set of clusters depending on the
nature of variables. Compared with the K-means method,
usually used as an alternative method of clustering, the LCA
has several advantages. Indeed, LCA allows the determination
of the number of clusters using the Bayesian information
criterion statistic, to classify cases into clusters using posterior
membership probabilities and to include demographics and
other exogenous variables (Magidson and Vermunt, 2002).
However, we acknowledge that no single method is best. Our
study data were collected prospectively on a standardized
case report form from consecutive patients. There were few
patients with missing data (4.6%). The study is reported in
accordance with STROBE guidelines.
However, this study also has several limitations. First, the
latent classes identified depend on the initial choice of
the number and nature of the latent indicators introduced in
the model. Given our sample size, we were not able to choose
more than 10 indicators. Second, the cross-sectional study
design precluded validation of our classification scheme based
on outcomes. Classification methods require a large number
of patients, therefore we were not able to split our sample to
obtain an independent validation data set. However, even
though it is not a formal validation, we found significant
differences between the obtained clusters regarding exogen-
ous variables, i.e., socio-demographic factors, disease severity,
age at disease onset, and disease duration. Last, given the
small number of centers, generalization of our findings should
be viewed with caution.
Our findings have two potential implications. First, our
findings invite the performance of basic studies, most notably
on genetic or immunologic biomarkers, to test whether the
three latent classes reflect different underlying biological,
physiological, or genetic patterns. A recent genetic study in
six Chinese families with atypical HS consistent with our
‘‘follicular’’ latent class suggests a role for PSEN gene muta-
tions in the pathogenesis of HS (Wang et al., 2010). Second,
our classification scheme should help establish homogenous
patient populations for clinical randomized trials.
Our findings based on a classification method involving no
pre-established definitions suggest three distinct phenotypes of
HS. The ‘‘axillary–mammary’’ phenotype with predominantly
anterior-body involvement in females is consistent with
descriptions of typical HS. It accounted for about half the
study population, with the other half being evenly divided
between two atypical phenotypes: the ‘‘follicular’’ form
characterized by follicular lesions, severe acne, and a pre-
dominance of men; and the ‘‘gluteal’’ form characterized by
selective involvement of the gluteal area. However, further
studies should be conducted to evaluate whether these
categories are significant in terms of biomarkers and genetic
background, disease course, outcome, and response to
treatment.
MATERIALS AND METHODS
Patients
For this cross-sectional study, we used a convenience sample of 648
consecutive patients with HS referred between 2002 and 2010 to the
Henri-Mondor Teaching Hospital, Creteil, France, and to a dermatol-
ogy medical office in Paris, France. These patients were prospectively
included in a database. The characteristics of 302 of the 648 patients
have been described elsewhere (Canoui-Poitrine et al., 2009).
Patients were interviewed and examined by a trained dermatologist
and the diagnosis was routinely validated by one of us (JR). The three
following criteria were required to diagnose HS: deep-seated nodules
(‘‘blind boils’’), abscesses, and/or fibrosis; involvement of the armpit
and groin (and, less importantly, of the breast, gluteal area, and
perineum); and a chronic course with recurrent and persistent lesions.
Data collection
The following data were collected prospectively on a standardized
form: age and sex; BMI (kg m 2); smoking status; age at HS onset;
disease duration on the evaluation day; personal history of acne,
Crohn’s disease, and/or inflammatory joint disease; a family history of
HS; and HS characteristics. The HS characteristics are listed below.
 Sites involved at least once: armpit, breast, gluteal area, groin,
perineum, intergluteal cleft, ears, chest, and others (e.g., neck,
back, abdomen, or legs).
 Lesion type: nodules, hypertrophic scars, comedones, papules and
folliculitis, epidermal cysts, macrocysts, and pilonidal sinuses.
 Sartorius severity score and Hurley stage. The Sartorius score takes
into account the number of body sites involved, the number and
scores of individual lesions, the longest distance between two
F Canoui-Poitrine et al.
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lesions, and whether the lesions are separated by normal skin.
Higher scores indicate greater severity (Sartorius et al., 2003).
Hurley’s stage was also determined for each involved body site
on the day of clinical examination (Hurley, 1989). For our
analyses, we took into consideration the stage of the most
severely affected site.
Statistical analysis
Quantitative variables are described as median (interquartile range)
and qualitative variables as number (%).
Identification of the underlying HS subtypes. LCA is a multi-
variate regression model that describes the relationships between
a set of observed dependent variables (‘‘latent class indicators’’;
here, the clinical features of HS) and an unobserved categorical
latent variable. The objective of LCA is to find the smallest
number of groups (i.e., latent classes) such that patients in one
group are similar to one another but distinct from patients in other
groups (Vermunt and Magidson, 2002; Reinecke, 2010). This
method was primarily developed in psychiatry and related fields
(Pickles et al., 1995; Kendler et al., 1998; Breslau et al., 2005;
Leoutsakos et al., 2010; Dechartres et al., 2011), and postulates
that the associations among a set of observed variables are the
result of a common underlying latent class structure. LCA has
been used in various medical fields, mainly as a means of
identifying homogenous patient groups without relying solely on
clinician perceptions (Silverwood et al., 2011). The estimated
indicators are used to classify patients according to their most
likely latent class. The number of indicators must be restricted
to allow convergence of the model; indicators with a high
prevalence (eg, inguinal location, 90%) are not suitable,
because they have no potential for discrimination. For our
study, we chose 10 indicators: 3 locations, namely, the armpit
and breast, gluteal region, and other locations (ears, chest, back,
neck, legs, or abdomen); 5 lesion types: hypertrophic scars,
comedones, epidermal cysts and macrocysts, papules and
folliculitis, and pilonidal sinus; acne or history of severe acne;
and family history of HS. The number of latent classes was
determined iteratively, beginning with a one-class model and
proceeding to test models with increasing numbers of classes.
Goodness-of-fit statistics were used to select the optimal model.
We compared successive models based on the Bayesian
information criterion, which should indicate the most
parsimonious solution, taking into account the number of
indicators (Schwarz, 1978). Information about the underlying
class structure is conveyed through the latent class probabilities,
or class prevalence estimates, which indicate the proportion
assigned to each class, and response probabilities, which are
the percentages of class members reporting each symptom. Then,
each patient was assigned to the most likely class, on the basis of
posterior probabilities from Bayes theory.Patients with missing
data were not included in the final analysis.
Factors associated with the latent classes. We used membership
in an identified class as a surrogate variable describing the pattern
of characteristics and symptoms. We used the Pearson w2 and
Kruskal–Wallis tests to compare classes regarding the distribution
of socio-demographic factors (gender, BMI, and smoking), disease
severity (Sartorius score and Hurley stage), age at disease onset,
and disease duration. Post hoc comparisons were performed with
Bonferroni’s correction. Associations between the above-listed
variables and membership in each class were quantified by the
odds ratio and 95% confidence interval, using multinomial
logistic regression. The dependent variable was the latent class.
Associations between age at disease onset and each class were
routinely adjusted for disease duration.
All comparisons were two sided, and Po0.05 was considered
significant. LCA was conducted using LatentGold (LatentGold
4.5, Statistical Innovations, Belmont, MA). Other analyses were
performed using the Stata Statistical software v11 (StataCorp
2003. Release 8.2. College Station, TX).
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